Business Context and Reporting Period
This Form 8-K filing by Heatwurx, Inc. (not Processa Pharmaceuticals, Inc.) reports corporate governance changes effective April 30, 2015. The registrant is a Delaware corporation headquartered in Gardena, CA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive departures, appointments, and equity compensation arrangements.
Material Changes
- Executive Departure: David Dworsky resigned as President and Chief Executive Officer (CEO) on April 30, 2015, after serving since November 2013. He remains a director.
- Executive Appointment: Heather Kearns was appointed Interim CEO on April 30, 2015. She previously served as Interim CFO and Controller for the company.
- Board Change: Glenn Russell was appointed as a director, replacing Stephan Garland, who resigned on March 17, 2015.
Compensation and Equity Arrangements
- David Dworsky: Granted 125,000 fully vested options at $1.50/share. Agreed to cancel 300,000 existing options.
- Heather Kearns: Granted a monthly salary of $9,000 plus travel expenses. Granted 125,000 options at $1.50/share (50% vested immediately, 50% vesting in one year).
- Glenn Russell: No compensation agreement finalized; a consulting agreement with an entity owned by Mr. Russell is anticipated but not yet executed.
Outlook and Risks
The filing does not contain financial guidance, management commentary on future operations, or specific risk factors beyond the leadership transition. The appointment of an interim CEO suggests a period of organizational adjustment.
Investor Verification Checklist
- Verify the exact terms of the anticipated consulting agreement with Glenn Russell's entity.
- Confirm the status of the 300,000 options cancelled by David Dworsky and the impact on total outstanding equity.
- Review subsequent filings for the appointment of a permanent CEO to replace the interim arrangement.
- Check for any undisclosed financial distress that may have precipitated the CEO resignation.